Our research interest was the association of CHMP2B-positive GVDs with tau pathology in the hippocampus, including the subiculum, CA2 and CA1 subfields, where GVDs were found in high number in AD as well as non-AD cases [18], [39]. This evidence concerns the gene CHMP2B and Alzheimer disease.